ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $68,159 | -48.6% | 13,714 | -49.0% | 0.11% | -33.7% |
| Q1 2023 | $132,723 | -32.7% | 26,867 | -14.3% | 0.16% | -28.5% |
| Q4 2022 | $197,122 | -21.2% | 31,339 | +35.4% | 0.23% | -20.3% |
| Q3 2022 | $250,000 | -41.9% | 23,137 | -38.6% | 0.29% | -3.4% |
| Q2 2022 | $430,000 | +205.0% | 37,713 | +144.1% | 0.30% | +179.2% |
| Q1 2022 | $141,000 | -7.8% | 15,449 | +51.1% | 0.11% | -35.0% |
| Q4 2021 | $153,000 | – | 10,223 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |